Literature DB >> 20963646

Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines.

Gabor Tarjan1, G Kenneth Haines, Benjamin J Vesper, Jiaping Xue, Michael B Altman, Yaroslav R Yarmolyuk, Huma Khurram, Kim M Elseth, John C Roeske, Bulent Aydogan, James A Radosevich.   

Abstract

It is not understood why some head and neck squamous cell carcinomas, despite having identical morphology, demonstrate different tumor aggressiveness, including radioresistance. High levels of the free radical nitric oxide (NO) and increased expression of the NO-producing enzyme nitric oxide synthase (NOS) have been implicated in tumor progression. We previously adapted three human tongue cancer cell lines to high NO (HNO) levels by gradually exposing them to increasing concentrations of an NO donor; the HNO cells grew faster than their corresponding untreated ("parent") cells, despite being morphologically identical. Herein we initially characterize the HNO cells and compare the biological properties of the HNO and parent cells. HNO/parent cell line pairs were analyzed for cell cycle distribution, DNA damage, X-ray and ultraviolet radiation response, and expression of key cellular enzymes, including NOS, p53, glutathione S-transferase-pi (GST-pi), apurinic/apyrimidinic endonuclease-1 (APE1), and checkpoint kinases (Chk1, Chk2). While some of these properties were cell line-specific, the HNO cells typically exhibited properties associated with a more aggressive behavior profile than the parent cells (greater S-phase percentage, radioresistance, and elevated expression of GST-pi/APE1/Chk1/Chk2). To correlate these findings with conditions in primary tumors, we examined the NOS, GST-pi, and APE1 expression in human tongue squamous cell carcinomas. A majority of the clinical samples exhibited elevated expression levels of these enzymes. Together, the results herein suggest cancer cells exposed to HNO levels can develop resistance to free radicals by upregulating protective mechanisms, such as GST-pi and APE1. These upregulated defense mechanisms may contribute to their aggressive expression profile.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963646     DOI: 10.1007/s13277-010-0102-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  48 in total

1.  Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.

Authors:  H Shiga; E I Heath; A A Rasmussen; B Trock; P G Johnston; A A Forastiere; M Langmacher; A Baylor; M Lee; K J Cullen
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

2.  Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines.

Authors:  Yaroslav R Yarmolyuk; Benjamin J Vesper; William A Paradise; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-10-23

3.  Characterization of a novel phantom for three-dimensional in vitro cell experiments.

Authors:  Michael B Altman; Benjamin J Vesper; Brett D Smith; Michelle A Stinauer; Charles A Pelizzari; Bulent Aydogan; Chester S Reft; James A Radosevich; Steven J Chmura; John C Roeske
Journal:  Phys Med Biol       Date:  2009-01-30       Impact factor: 3.609

4.  Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck.

Authors:  B G Bentz; G K Haines; M W Lingen; H J Pelzer; D G Hanson; J A Radosevich
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-08       Impact factor: 1.547

Review 5.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

6.  Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas.

Authors:  F Puglisi; G Aprile; A M Minisini; F Barbone; P Cataldi; G Tell; M R Kelley; G Damante; C A Beltrami; C Di Loreto
Journal:  Anticancer Res       Date:  2001 Nov-Dec       Impact factor: 2.480

7.  Radiosensitization of hypoxic tumor cells in vitro by nitric oxide.

Authors:  R J Griffin; C M Makepeace; W J Hur; C W Song
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-09-01       Impact factor: 7.038

8.  The topoisomerase I poison camptothecin generates a Chk1-dependent DNA damage checkpoint signal in fission yeast.

Authors:  S Wan; H Capasso; N C Walworth
Journal:  Yeast       Date:  1999-07       Impact factor: 3.239

9.  Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation.

Authors:  Julie K Schwarz; Christine M Lovly; Helen Piwnica-Worms
Journal:  Mol Cancer Res       Date:  2003-06       Impact factor: 5.852

Review 10.  The many functions of APE1/Ref-1: not only a DNA repair enzyme.

Authors:  Gianluca Tell; Franco Quadrifoglio; Claudio Tiribelli; Mark R Kelley
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

View more
  4 in total

1.  Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines.

Authors:  Yaroslav R Yarmolyuk; Benjamin J Vesper; William A Paradise; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-10-23

2.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

3.  A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties.

Authors:  Madeeha Aqil; Kim M Elseth; Ashok Arjunakani; Philip Nebres; Courtney P Amegashie; Devang H Thanki; Premal B Desai; James A Radosevich
Journal:  Tumour Biol       Date:  2014-12-11

4.  Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways.

Authors:  Madeeha Aqil; Kim M Elseth; Benjamin J Vesper; Zane Deliu; Bulent Aydogan; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.